US equity markets steadily advanced in March with the Dow Jones Industrial Average, S&P 500 and NASDAQ improving 7.1%, 6.6% and 6.8%, respectively. Investors reacted favorably to US Federal Reserve Chair Janet Yellen’s dovish stance, as she advocated a more cautious approach to policy changes due to the fragile global economic environment. Consequently, the US […]
According to BIO Deutschland’s annual biotechnology sector survey, the German biotech industry is optimistic for 2016. Many companies are planning to invest more in R&D and company personnel, with a little less than 60% of firms expecting business in the biotech sector to improve. Generally, two thirds of respondents believe nothing will change for German […]
A total of 500 research institutes won 60% of Europe’s €55 billion ($59.5 billion) Seventh Framework Programme (FP7) budget, according to an independent review completed late last month by international academics. The review analyzed the effects that FP7 had on scientific and economic growth, finding that 85% of FP7 funding was allotted to research firms […]
This month, the Irish government launched Innovation 2020, a five-year science strategy that sets out a road map for educational programs and institutions, and research industries. The goal is for public and private investment in Irish R&D to reach 2.5% of GNP by 2020. The strategy will focus investments on six industries: ICT; health and […]
In 2014, Spain’s internal expenditure on biotechnology R&D increased 1.5% to €1,450 million ($1.6 billion), or 11% of Spain’s annual R&D expenditures. The public administration sector accounted for 38% of biotech R&D internal expenditures, a 0.7% decrease. The business sector represented 37%, a 3.8% increase. The number of firms conducting R&D in the biotech industry […]
Published this month by the European Commission (EC), the 2015 EU Industrial R&D Scoreboard tracked the spending of 2,500 publicly held companies in 44 countries across 41 industries that are the world’s largest R&D spenders. Together, these companies represented an estimated 90% of global business R&D and 55% of total R&D spending in fiscal 2014 […]
Spain has announced the creation of the State Research Agency, which will fund scientific research. It replaces the State Secretariat for Research Development and Innovation. It will not receive new funding but rather reallocated funding. The new Agency will have around 300 employees and will be formed through a spin-off of resources from the Secretariat. […]
The latest UK spending review includes increased funding for science, providing an additional £500 million ($769 million) per year by 2020 for the £4.7 billion science budget in order to account for inflation. In addition, the science infrastructure budget will increase 10% to £1.2 billion per year by 2021 and includes £150 million for a […]
The EU’s 2016 budget was adopted by the European Parliament on November 25, restoring funding for the EU’s Horizon 2020 program that had been cut in the draft budget. Horizon 2020 is the EU’s primary mechanism for funding scientific research, with an estimated $103.4 billion budget from 2014 to 2020 (see IBO 12/31/13). Compared to […]
The EU has named a seven-person Scientific Advice Mechanism (SAM) that will assist the European Commission (EC) with science-related policies and decisions. The panel replaces the position of the chief scientific advisor, the last of whom resigned in 2014. Allocated €6 million ($6 million) and its own staff, the SAM is designed to be an […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
